Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 832562, 8 pages
http://dx.doi.org/10.1155/2014/832562
Research Article

Overexpression of Wnt5a Promotes Angiogenesis in NSCLC

1Department of Pathology, Tianjin Medical University, Tianjin 300070, China
2Department of Pathology, Affiliated Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui 230001, China
3Department of Pathology, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin 300060, China
4Department of Pathology, Tianjin General Hospital, Tianjin Medical University, Tianjin 300052, China

Received 5 May 2014; Accepted 13 May 2014; Published 5 June 2014

Academic Editor: Shiwu Zhang

Copyright © 2014 Lingli Yao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA: A Cancer Journal for Clinicians, vol. 64, pp. 9–29, 2014. View at Publisher · View at Google Scholar
  2. M. B. Beasley, E. Brambilla, and W. D. Travis, “The 2004 World Health Organization classification of lung tumors,” Seminars in Roentgenology, vol. 40, no. 2, pp. 90–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Tao, G. Huang, S. Shi, and L. Chen, “Bevacizumab improves the antitumor efficacy of adoptive cytokine-induced killer cells therapy in non-small cell lung cancer models,” Medical Oncology, vol. 31, p. 777, 2014. View at Publisher · View at Google Scholar
  4. A. Pircher, I. K. Wasle, M. Mian et al., “Docetaxel in the treatment of non-small cell lung cancer (NSCLC)—an observational study focusing on symptom improvement,” Anticancer Research, vol. 33, pp. 3831–3836, 2013. View at Google Scholar
  5. M. Christodoulou, N. Bayman, P. McCloskey, C. Rowbottom, and C. Faivre-Finn, “New radiotherapy approaches in locally advanced non-small cell lung cancer,” European Journal of Cancer, vol. 50, pp. 525–534, 2014. View at Publisher · View at Google Scholar
  6. V. L. Keedy, S. Temin, M. R. Somerfield et al., “American Society of clinical oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy,” Journal of Clinical Oncology, vol. 29, no. 15, pp. 2121–2127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Folkman, “Tumor angiogenesis: therapeutic implications,” The New England Journal of Medicine, vol. 285, no. 21, pp. 1182–1186, 1971. View at Google Scholar · View at Scopus
  8. J. Folkman, “Angiogenesis in cancer, vascular, rheumatoid and other disease,” Nature Medicine, vol. 1, no. 1, pp. 27–31, 1995. View at Google Scholar · View at Scopus
  9. H. Park, H. Y. Jung, H. J. Choi et al., “Distinct roles of DKK1 and DKK2 in tumor angiogenesis,” Angiogenesis, vol. 17, pp. 221–234, 2014. View at Publisher · View at Google Scholar
  10. J. A. Stefater III, I. Lewkowich, S. Rao et al., “Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells,” Nature, vol. 474, no. 7352, pp. 511–516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. N. H. Masckauchán, D. Agalliu, M. Vorontchikhina et al., “Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2,” Molecular Biology of the Cell, vol. 17, no. 12, pp. 5163–5172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Cheng, B. Sun, Z. Liu et al., “Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition,” Journal of Cellular Physiology, 2014. View at Publisher · View at Google Scholar
  13. M. Fernandez-Cobo, F. Zammarchi, J. Mandeli, J. F. Holland, and B. G. T. Pogo, “Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells,” Oncology Reports, vol. 17, no. 4, pp. 903–907, 2007. View at Google Scholar · View at Scopus
  14. H. Bo, S. Zhang, L. Gao et al., “Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells,” BMC Cancer, vol. 13, article 496, 2013. View at Google Scholar
  15. G. T. Lee, D. I. Kang, Y. S. Ha et al., “Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction,” The British Journal of Cancer, vol. 110, pp. 1634–1644, 2014. View at Publisher · View at Google Scholar
  16. M. Kanzawa, S. Semba, S. Hara, T. Itoh, and H. Yokozaki, “WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells,” Pathobiology, vol. 80, no. 5, pp. 235–244, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Jiang, D. K. Crossman, E. H. Mitchell, P. Sohn, M. R. Crowley, and R. Serra, “WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells,” PLoS ONE, vol. 8, no. 3, Article ID e58329, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Bi, X. Liu, C. Wang et al., “Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma,” International Journal of Clinical and Experimental Pathology, vol. 7, pp. 987–995, 2014. View at Google Scholar
  19. D.-H. Yang, J.-Y. Yoon, S.-H. Lee et al., “Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/β-Catenin and protein kinase Cα,” Circulation Research, vol. 104, no. 3, pp. 372–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C.-L. Huang, D. Liu, J. Nakano et al., “Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor—an expression in non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 23, no. 34, pp. 8765–8773, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. W. D. Travis, E. Brambilla, M. Noguchi et al., “International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma,” Journal of Thoracic Oncology, vol. 6, no. 2, pp. 244–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Zhang, B. Sun, X. Zhao et al., “Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma,” Journal of Surgical Oncology, vol. 108, no. 6, pp. 414–419, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Sun, N. Zhao, X.-L. Zhao et al., “Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry,” Hepatology, vol. 51, no. 2, pp. 545–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Sun, B.-C. Sun, X.-L. Zhao et al., “Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma,” Hepatology, vol. 54, no. 5, pp. 1690–1706, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Bittner, P. Meltzer, Y. Chen et al., “Molecular classification of cutaneous malignant melanoma by gene expression profiling,” Nature, vol. 406, no. 6795, pp. 536–540, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Lange, E. Mix, K. Rateitschak, and A. Rolfs, “Wnt signal pathways and neural stem cell differentiation,” Neurodegenerative Diseases, vol. 3, no. 1-2, pp. 76–86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Herzlinger, J. Qiao, D. Cohen, N. Ramakrishna, and A. M. C. Brown, “Induction of kidney epithelial morphogenesis by cells expressing Wnt-1,” Developmental Biology, vol. 166, no. 2, pp. 815–818, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. T. C. Dale, “Signal transduction by the Wnt family of ligands,” Biochemical Journal, vol. 329, no. 2, pp. 209–223, 1998. View at Google Scholar · View at Scopus
  29. Z. You, D. Saims, S. Chen et al., “Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis,” Journal of Cell Biology, vol. 157, no. 3, pp. 429–440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Reya and H. Clevers, “Wnt signalling in stem cells and cancer,” Nature, vol. 434, no. 7035, pp. 843–850, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Nakashima, C.-L. Huang, D. Liu, M. Ueno, and H. Yokomise, “Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancer,” International Journal of Oncology, vol. 37, no. 3, pp. 687–694, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Heikkil, H. Peltoketo, and S. Vainio, “Wnts and the female reproductive system,” Journal of Experimental Zoology, vol. 290, no. 6, pp. 616–623, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. O. Kovalchuk, A. Ponton, J. Filkowski, and I. Kovalchuk, “Dissimilar genome response to acute and chronic low-dose radiation in male and female mice,” Mutation Research, vol. 550, no. 1-2, pp. 59–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. A. J. Maniotis, R. Folberg, A. Hess et al., “Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry,” The American Journal of Pathology, vol. 155, no. 3, pp. 739–752, 1999. View at Google Scholar · View at Scopus
  35. J. Du, B. Sun, X. Zhao et al., “Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma,” Gynecologic Oncology, 2014. View at Publisher · View at Google Scholar
  36. H. J. Chung and M. Mahalingam, “Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma—implications for therapeutic strategies and targeted therapies,” Expert Review of Anticancer Therapy, vol. 14, no. 5, pp. 621–639, 2014. View at Publisher · View at Google Scholar
  37. J. T. Zhang, W. Sun, W. Z. Zhang et al., “Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5gamma2 signaling pathway,” BMC Cancer, vol. 14, article 193, 2014. View at Publisher · View at Google Scholar
  38. F. Luo, K. Yang, R. L. Liu, C. Meng, R. F. Dang, and Y. Xu, “Formation of vasculogenic mimicry in bone metastasis of prostate cancer: correlation with cell apoptosis and senescence regulation pathways,” Pathology: Research and Practice, vol. 210, pp. 291–295, 2014. View at Publisher · View at Google Scholar
  39. K. Chiablaem, K. Lirdprapamongkol, S. Keeratichamroen, R. Surarit, and J. Svasti, “Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition,” Anticancer Research, vol. 34, pp. 1857–1864, 2014. View at Google Scholar
  40. Y. S. Chen and Z. P. Chen, “Vasculogenic mimicry: a novel target for glioma therapy,” Chinese Journal of Cancer, vol. 33, pp. 74–79, 2014. View at Publisher · View at Google Scholar
  41. W.-B. Liu, G.-L. Xu, W.-D. Jia et al., “Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma,” Medical Oncology, vol. 28, supplement 1, pp. S228–S238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. X. He, J.-P. Saint-Jeannet, Y. Wang, J. Nathans, I. Dawid, and H. Varmus, “A member of the frizzled protein family mediating axis induction by Wnt-5A,” Science, vol. 275, no. 5306, pp. 1652–1654, 1997. View at Publisher · View at Google Scholar · View at Scopus